Related Experiment Videos
In-center daily on-line hemodiafiltration: a 4-year experience in children
1Nephrology Dialysis Transplantation Children's Unit, Strasbourg, France.
Insights
Daily hemodiafiltration (DIH) in children improved growth and reduced medication needs. This intensive dialysis regimen allowed for free-diet intake and catch-up growth in prepubertal patients.
Area of Science:
- Pediatric Nephrology
- Renal Replacement Therapy
- Dialysis Techniques
Background:
- Pediatric patients on dialysis often face dietary restrictions, medication burdens, and growth retardation.
- Traditional dialysis modalities may not fully address the complex needs of growing children with end-stage renal disease.
- The transition from peritoneal dialysis to hemodiafiltration presents unique challenges and opportunities.
Purpose of the Study:
- To evaluate the efficacy of an in-center daily on-line hemodiafiltration (DIH) program in pediatric patients.
- To assess the impact of DIH on nutritional status, medication requirements, and statural growth.
- To explore the quality of life and compliance associated with intensive daily dialysis.
Main Methods:
- A cohort of 12 children underwent in-center daily on-line hemodiafiltration (DIH) for 3-hour sessions, 5-6 times weekly.
- Vascular access included central catheters or fistulas; 7 children were converted from peritoneal dialysis.
- Monthly assessments monitored dialysis adequacy (KT/Vurea), phosphatemia, diet, medications, and statural growth.
Main Results:
- DIH facilitated a transition from restrictive diets to free intake with high protein consumption.
- Significant reductions in antihypertensive drugs and phosphate/potassium chelators were observed.
- Prepubertal children experienced catch-up growth, with a median growth rate of 0.8 cm/month.
- Predialysis phosphatemia remained within the normal range without the need for phosphate binders in most patients.
Conclusions:
- Daily on-line hemodiafiltration (DIH) is an effective treatment for pediatric end-stage renal disease, promoting catch-up growth.
- DIH significantly reduces the need for antihypertensive medications and phosphate binders, improving patient quality of life.
- This intensive dialysis approach fosters natural compliance and a better way of life for children and their families.
Abstract:
Our daily dialysis program was started in September 2002: in-center daily on-line hemodiafiltration (DIH) was carried out in 3-hour sessions, 5 - 6 times weekly, on-line assessment KT/Vurea of minimal 1.5 per session, polysulfone membranes. 12 children were included: median age 7.4 years (2.10 - 16.8 years), renal residual function less than 3 ml/min/1.73 m2 (Kcreat + Kurea/2), vascular access central catheter (n = 4) or fistula (n = 8), 7/12 being converted from peritoneal dialysis to DIH. Median follow-up on DIH was 11 months (4 - 43 months), endpoint was kidney transplantation (11/12) or transfer to another center (1/12). Monthly assessments of dialysis parameters (KT/Vurea, predialysis phosphatemia), diet survey (3 consecutive days), medications (number of antihypertensive drugs, phosphate chelators, potassium chelators) and statural growth were performed. At start of DIH, diet intake due to medical prescription and limited appetite was restrictive with limitation in water, salt (20 mmol/day), potassium and proteins (median 35 g/day, range 20 - 80 g); only 2/12 children were free of antihypertensive drugs, all received phosphate and potassium chelators, and growth retardation occurred (7/12 in prepubertal children, median height SDS -1.52) despite rhGH therapy (5/12 patients). At the end of DIH, diet was free, protein intake high (2 - 3 g/kg/day, range 30 - 100), 10/12 children were free of antihypertensive drugs, 4/12 received potassium chelators, 1/12 received phosphate chelators. All the prepubertal children at inclusion (n = 7) showed catch-up growth with a median growth rate of 0.8 cm/month (0.5 - 1.6 cm/ month). DIH allowed to maintain predialysis phosphatemia in a low normal range (median 1.23 mmol/l, range 1.65 - 0.63), without (11/12 children) need of phosphate chelators. Thanks to DIH children, parents and team care discovered during DIH a new way of life with motivated children, showing natural compliance (no diet restriction, no or few drugs), and most of all children developing with catch-up of growth.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Continuous Renal Replacement Therapy
Hemodialysis III: Nursing Management